|
GW406108X
|
G419978-1mg
|
≥98% |
1644443-92-4 |
1mg
|
¥ 528.9
|
现货 |
|
0 |
阿拉丁 |
|
GW406108X
|
G419978-10mg
|
≥98% |
1644443-92-4 |
10mg
|
¥ 2608.9
|
现货 |
|
0 |
阿拉丁 |
|
GW406108X
|
G419978-100mg
|
≥98% |
1644443-92-4 |
100mg
|
¥ 10263.9
|
现货 |
|
0 |
阿拉丁 |
|
KPT 9274 ( ATG-019)
|
K414012-50mg
|
Moligand™, ≥98% |
1643913-93-2 |
50mg
|
¥ 10299.9
|
现货 |
|
0 |
阿拉丁 |
|
KPT 9274 ( ATG-019)
|
K414012-10mg
|
Moligand™, ≥98% |
1643913-93-2 |
10mg
|
¥ 3150.9
|
现货 |
|
0 |
阿拉丁 |
|
N,N-二甲基十二烷胺-N-氧化物(DDAO)
|
D106281-100g
|
≥95% |
1643-20-5 |
100g
|
¥ 4519.9
|
现货 |
|
0 |
阿拉丁 |
|
葡美替尼(SCC244)
|
G414110-50mg
|
Moligand™, ≥98% |
1642581-63-2 |
50mg
|
¥ 951.9
|
现货 |
|
0 |
阿拉丁 |
|
葡美替尼(SCC244)
|
G414110-25mg
|
Moligand™, ≥98% |
1642581-63-2 |
25mg
|
¥ 845.9
|
现货 |
|
0 |
阿拉丁 |
|
葡美替尼(SCC244)
|
G414110-10mg
|
Moligand™, ≥98% |
1642581-63-2 |
10mg
|
¥ 367.9
|
现货 |
|
0 |
阿拉丁 |
|
葡美替尼(SCC244)
|
G414110-100mg
|
Moligand™, ≥98% |
1642581-63-2 |
100mg
|
¥ 1713.9
|
现货 |
|
0 |
阿拉丁 |
|
Mavacamten (MYK-461)
|
M414228-50mg
|
Moligand™, ≥99% |
1642288-47-8 |
50mg
|
¥ 4077.9
|
现货 |
|
0 |
阿拉丁 |
|
Mavacamten (MYK-461)
|
M414228-1mg
|
Moligand™, ≥99% |
1642288-47-8 |
1mg
|
¥ 510.9
|
现货 |
|
0 |
阿拉丁 |
|
Mavacamten (MYK-461)
|
M414228-100mg
|
Moligand™, ≥99% |
1642288-47-8 |
100mg
|
¥ 7414.9
|
现货 |
|
0 |
阿拉丁 |
|
甘氨脱氧胆酸钠
|
S102123-25g
|
≥97% |
16409-34-0 |
25g
|
¥ 2597.9
|
现货 |
|
0 |
阿拉丁 |
|
奥拉替尼马来酸盐
|
O413939-500mg
|
≥98% |
1640292-55-2 |
500mg
|
¥ 9268.9
|
现货 |
|
0 |
阿拉丁 |
|
奥拉替尼马来酸盐
|
O413939-25mg
|
≥98% |
1640292-55-2 |
25mg
|
¥ 2038.9
|
现货 |
|
0 |
阿拉丁 |
|
PZ-II-029,α6β3γ2-GABAA正构变构调节剂
|
P287515-50mg
|
Moligand™, ≥98%(HPLC) |
164025-44-9 |
50mg
|
¥ 3559.9
|
现货 |
|
0 |
阿拉丁 |
|
PZ-II-029,α6β3γ2-GABAA正构变构调节剂
|
P287515-10mg
|
Moligand™, ≥98%(HPLC) |
164025-44-9 |
10mg
|
¥ 919.9
|
现货 |
|
0 |
阿拉丁 |
|
PZ-II-029,α6β3γ2-GABAA正构变构调节剂
|
P287515-100mg
|
Moligand™, ≥98%(HPLC) |
164025-44-9 |
100mg
|
¥ 6334.9
|
现货 |
|
0 |
阿拉丁 |
|
3,3',5,5'-四溴-1,1'-联苯
|
T134315-250mg
|
≥97% |
16400-50-3 |
250mg
|
¥ 57.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-(-)-DBD-Py-NCS [=(R)-(-)-4-(N,N-二甲氨基磺酰基)-7-(3-异硫氰酸基四氢吡咯-1-基)-2,1,3-苯并恶二唑][用于高效液相色谱标记]
|
R160963-50mg
|
≥98%(HPLC) |
163927-31-9 |
50mg
|
¥ 1750.9
|
现货 |
|
0 |
阿拉丁 |
|
(S)-(+)-NBD-Py-NCS [=(S)-(+)-4-(3-异硫氰酸基吡咯烷-1-基)-7-硝基-2,1,3-苯并恶二唑][用于旋光纯度测定的高效液相色谱标记试剂]
|
S160991-50mg
|
≥98%(HPLC) |
163927-30-8 |
50mg
|
¥ 647.9
|
现货 |
|
0 |
阿拉丁 |
|
(R)-(-)-NBD-Py-NCS [=(R)-(-)-4-(3-异硫氰酸基吡咯烷-1-基)-7-硝基-2,1,3-苯并恶二唑][用于旋光纯度测定的高效液相色谱标记试剂]
|
R160964-50mg
|
≥98%(HPLC) |
163927-29-5 |
50mg
|
¥ 613.9
|
现货 |
|
0 |
阿拉丁 |
|
二乙氧基苯膦
|
D338519-25g
|
≥97% |
1638-86-4 |
25g
|
¥ 285.9
|
现货 |
|
0 |
阿拉丁 |